Canakinumab treatment in kidney transplant recipients with AA amyloidosis due to familial Mediterranean fever-Reference-Cited by-同舟云学术

Canakinumab treatment in kidney transplant recipients with AA amyloidosis due to familial Mediterranean fever

Published:2018-07-22 Issue:8 Volume:32 Page:e13345
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Trabulus Sinan¹,Korkmaz Merve²,Kaya Eda³,Seyahi Nurhan¹^ORCID

Affiliation:

1. Division of Nephrology; Department of Internal Medicine; Cerrahpasa Medical Faculty; Istanbul University; Istanbul Turkey

2. Department of Internal Medicine; Cerrahpasa Medical Faculty; Istanbul University; Istanbul Turkey

3. Cerrahpasa Medical Faculty; Istanbul University; Istanbul Turkey

Publisher

Wiley

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ctr.13345/fullpdf

Reference14 articles.

1. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study;Tunca;Medicine (Baltimore),2005

2. Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicenter study;Kasifoglu;Rheumatology (Oxford),2014

3. Renal transplantation in amyloidosis secondary to familial Mediterranean fever;Sever;Transplant Proc,2001

4. Current status of renal replacement therapies in Turkey: Turkish society of nephrology registry 2015 summary report;Suleymanlar;Turk Nephrol Dial Transplant,2017

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study;Expert Opinion on Biological Therapy;2023-11-17

2. Novel Therapeutic Approaches in the Management of Chronic Kidney Disease;Biomedicines;2023-10-11

3. Characteristics and course of patients with AA amyloidosis: single centre experience with 174 patients from Turkey;Rheumatology;2023-09-20

4. Kidney Transplantation in Patients With AA Amyloidosis: Outcomes in a French Multicenter Cohort;American Journal of Kidney Diseases;2023-09

5. Renal AA amyloidosis: presentation, diagnosis, and current therapeutic options: a review;Kidney International;2023-03